B&L Unit To Pay $34M For Drug Marketing Guilty Plea: DOJ
A Bausch & Lomb Inc. affiliate will cough up $33.5 million as part of an agreement copping to federal charges that it promoted an anti-inflammatory eye-treatment drug for unapproved new uses...To view the full article, register now.
Already a subscriber? Click here to view full article